Abstract
Aim:
To study the effect of doxycycline (DOX) on osteoclastogenesis, mature osteoclast fate and function, wear particles-induced osteoeolysis, and to provide some foundation for treating aseptic loosening and osteolysis after joint arthroplasty.
Methods:
Osteoclasts were generated from mouse bone marrow monocytes with the receptor activator of NF-κB ligand and the macrophage colony stimulating factor. DOX at a concentration of 5, 10, 15, and 20 μg/mL was respectively added to the medium. Seven days later, the osteoclasts were determined through tartrate-resistant acid phosphatase (TRAP) staining. Mature osteoclasts were isolated from newborn rabbits and cultured for 3 d in 24-well plates or on bone slices. DOX at a concentration of 5, 10, 15, and 20 μg/mL was respectively added to the medium. After TRAP staining, the osteoclasts were counted, resorption on bone slices was quantified, and the area was calculated after toluidine blue and Mayer-hematoxylin staining. Polymethyl methacrylate (PMMA) or ultra-high molecular weight polyethylene (UHMWPE) particles were implanted on the calvariae of C57BL/J6 mice. DOX, at a dose of 2 and 10 mg·kg−1·d−1, was respectively given intraperitoneally for 7 d. Seven days later, the calvariae were removed and processed for pathological analysis.
Results:
DOX treatment effectively inhibited in vitro osteoclastogenesis, affected the fate of mature osteoclasts, and inhibited mature osteoclasts, causing bone resorption. In vivo data indicated that DOX strongly inhibited PMMA or UHMWPE-induced osteolysis and osteoclastogenesis.
Conclusion:
DOX can effectively inhibit osteoclastogenesis and affect mature osteoclast fate and suppress wear particles induced by osteolysis and osteoclastogenesis. DOX might be useful in the treatment or prevention of wear particles-induced osteolysis and aseptic loosening for its effect on osteoclast generation and mature osteoclast fate and function.
Similar content being viewed by others
Article PDF
References
Harris WH . Wear and periprosthetic osteolysis: the problem. Clin Orthop 2001; 393: 66–70.
Bauer TW . Particles and periimplant bone resorption. Clin Orthop 2002; 405: 138–43.
Baumann B, Rader CP, Seufert J, Noth U, Rolf O, Eulert J, et al. Effects of polyethylene and TiA1V wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthop 2004; 75: 295–302.
Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT . The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 2006; 54: 3221–32.
Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L, et al. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 2002; 23: 517–26.
Yang SY, Wu B, Mayton L, Mukherjee P, Robbins PD, Evans CH, et al. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 2004; 115: 483–91.
Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT . Osteolysis: basic science. Clin Orthop 2001; 393: 71–7.
Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM . Efficacy of etanercept for wear debris-induced osteolysis. J Bone Min Res 2001; 16: 338–47.
Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, Smith RL, et al. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 2005; 23: 501–10.
Rawal SY, Rawal YB . Non-antimicrobial properties of tetracy-clines-dental and medical implications. West Indian Med J 2001; 50: 105–8.
Bettany JT, Peet NM, Wolowacz RG, Skerry TM, Grabowski PS . Tetracyclines induce apoptosis in osteoclasts. Bone 2000; 27: 75–80.
Holmes SG, Still K, Buttle DJ, Bishop NJ, Grabowski PS . Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone 2004; 35: 471–8.
Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM . Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 2001; 83: 1789–97.
Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000; 18: 849–55.
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597–602.
Sobue T, Hakeda Y, Kobayashi Y, Hayakawa H, Yamashita K, Aoki T, et al. Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J Bone Miner Res 2001; 16: 2205–14.
Ragab AA, Van De Motter R, Lavish SA, Goldberg VM, Ninomiya JT, Carlin CR, et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999; 17: 803–9.
Munger P, Roder C, Ackermann-Liebrich U, Busato A . Patient-related risk factors leading to aseptic stem loosening in total hip arthroplasty: a case-control study of 5,035 patients. Acta Orthop 2006; 77: 567–74.
Wright TM, Goodman SB . Implant wear in total joint replacement: clinical and biologic issues, material and design considerations. American Academy of Orthopaedic Surgeons; 2001. ( http://www4.aaos.org/product/productpage.cfm?code=02522).
Porter ML . The long-term results of Charnley low-friction arthroplasty in young patients who have congenital dislocation, degenerative osteoarthrosis, or rheumatoid arthritis. J Bone Joint Surg Am. 1997; 79-Am: 1599–617.
von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Brankamp J, et al. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A 2005; 75: 288–94.
Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ . Viral interleukin-10 gene inhibition of inflammation, osteoclasto-genesis, and bone resorption in response to titanium particles. Arthritis Rheum 2002; 46: 1298–308.
Iwase M, Kim KJ, Kobayashi Y, Itoh M, Itoh T . A novel bisphos-phonate inhibits inflammatory bone resorption in a rat osteoly-sis model with continuous infusion of polyethylene particles. J Orthop Res 2002; 20: 499–505.
Wise LM, Waldman SD, Kasra M, Cheung R, Binnington A, Kandel RA, et al. Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog. Calcif Tissue Int 2005; 77: 367–75.
von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Henschke F, et al. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 2005; 26: 3549–55.
Schwarz EM, Campbell D, Totterman S, Boyd A, O'Keefe RJ, Looney RJ . Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs placebo. J Orthop Res 2003; 21: 1049–55.
Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Chen HS . The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty. J Bone Joint Surg Am 2003; 85-Am: 2121–6.
Talmo CT, Shanbhag A, Rubash HE . Nonsurgical management of osteolysis: challenges and opportunities. Clin Orthop 2006; 453: 254–64.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, C., Tang, Tt., Ren, Wp. et al. Inhibiting wear particles-induced osteolysis with doxycycline. Acta Pharmacol Sin 28, 1603–1610 (2007). https://doi.org/10.1111/j.1745-7254.2007.00638.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00638.x
Keywords
This article is cited by
-
Doxycycline reduces osteopenia in female rats
Scientific Reports (2019)
-
Doxycycline induces bone repair and changes in Wnt signalling
International Journal of Oral Science (2017)
-
Tetracyclines Inhibit Rat Osteoclast Formation and Activity In Vitro and Affect Bone Turnover in Young Rats In Vivo
Calcified Tissue International (2010)